NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 350 filers reported holding NOVAVAX INC in Q4 2020. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1 | -50.0% | 200 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $2 | -100.0% | 200 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $4,000 | -60.0% | 200 | 0.0% | 0.00% | -60.0% |
| Q2 2022 | $10,000 | -33.3% | 200 | 0.0% | 0.01% | -16.7% |
| Q1 2022 | $15,000 | -48.3% | 200 | 0.0% | 0.01% | -45.5% |
| Q4 2021 | $29,000 | -29.3% | 200 | 0.0% | 0.01% | -35.3% |
| Q3 2021 | $41,000 | -4.7% | 200 | 0.0% | 0.02% | -5.6% |
| Q2 2021 | $43,000 | +19.4% | 200 | 0.0% | 0.02% | +5.9% |
| Q1 2021 | $36,000 | +63.6% | 200 | 0.0% | 0.02% | +54.5% |
| Q4 2020 | $22,000 | -12.0% | 200 | 0.0% | 0.01% | -15.4% |
| Q3 2020 | $25,000 | – | 200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |